Ipilimumab (anti-CTLA-4)
Product Specifications
CAS Number
477202-00-9
Synonyms
MDX-010, BMS-734016
SKU
C00002-1mg
Target
Immunology & Inflammation related
Applications
Immunology & Inflammation
Additionnal Information
Ipilimumab (anti-CTLA-4) is an immunomodulatory monoclonal antibody directed against the cell surface antigen CTLA-4 and also a type of immune checkpoint inhibitor. MW : 148 kD.
Storage Conditions
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6234751-01 0.1 mL
PSMC2 (26S Protease Regulatory Subunit 7, Proteasome 26S Subunit ATPase 2, 26S Proteasome AAA-ATPase Subunit RPT1, Protein MSS1, MSS1) (MaxLight 750)
Ask
View Details MBS6234751-02 5x 0.1 mL
PSMC2 (26S Protease Regulatory Subunit 7, Proteasome 26S Subunit ATPase 2, 26S Proteasome AAA-ATPase Subunit RPT1, Protein MSS1, MSS1) (MaxLight 750)
Ask
View Details 
302728-ML405 100 µL
SAPS2 (Serine/Threonine-Protein Phosphatase 6 Regulatory Subunit 2, SAPS Domain Family Member 2, PPP6R2, KIAA0685, PP6R2, SAPS2) (MaxLight 405) discontinued
Ask
View Details 
MBS2050409-01 0.1 mL
Cy3-Linked Polyclonal Antibody to Low Density Lipoprotein Receptor (LDLR)
Ask
View Details MBS2050409-02 0.2 mL
Cy3-Linked Polyclonal Antibody to Low Density Lipoprotein Receptor (LDLR)
Ask
View Details MBS2050409-03 0.5 mL
Cy3-Linked Polyclonal Antibody to Low Density Lipoprotein Receptor (LDLR)
Ask
View Details